Skip to content

EWTX

Edgewise Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$39.63-0.33%

Price as of Jul 20, 2026

EWTX earnings

Edgewise Therapeutics, Inc. earnings

Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.

Next earnings
Aug 6, 2026in NaN days
EPS est $-0.48 · Revenue est
Track record
Beat EPS in 8 of 12 quarters
Avg surprise +4.0% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 7, 2026$-0.50$-0.46+8.0%
Feb 26, 2026$-0.43$-0.49-13.5%
Nov 6, 2025$-0.40$-0.39+2.5%
Aug 7, 2025$-0.42$-0.34+19.0%
May 8, 2025$-0.45$-0.43+4.4%
Mar 3, 2025$-0.39$-0.42-7.7%
Nov 7, 2024$-0.37$-0.36+2.7%
Aug 8, 2024$-0.36$-0.34+5.6%
May 9, 2024$-0.39$-0.33+15.4%
Feb 22, 2024$-0.44$-0.47-6.8%$2M
Nov 9, 2023$-0.40$-0.41-2.5%
Aug 10, 2023$-0.41$-0.34+17.1%

Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-06.